Skip to main content

Advertisement

Table 1 Efficacy of concurrent immunoradiotherapy

From: Immunotherapy Bridge 2018 and Melanoma Bridge 2018: meeting abstracts

  All Nivo-RT Ipi-RT
All Inside Outside All Inside Outside All Inside Outside
CR 1 1 1 0 0 0 1 1 1
PR 5 10 0 5 8 0 0 2 0
SD 2 4 7 1 0 6 1 4 1
PD 12 1 12 4 0 4 8 1 8
NE 0 4 0 0 2 0 0 2 0
Response rate (%) 30.0 68.8 5.0 50.0 100.0 0.0 10.0 37.5 10.0
Disease control rate (%) 40.0 93.8 40.0 60.0 100.0 60.0 20.0 87.5 20.0